UNC10217938A
目录号: PL08569 纯度: ≥99%
CAS No. :1347749-97-6
商品编号 规格 价格 会员价 是否有货 数量
PL08569-5mg 5mg ¥3857.00 请登录
PL08569-10mg 10mg ¥7232.00 请登录
PL08569-25mg 25mg ¥13179.00 请登录
PL08569-50mg 50mg ¥22341.00 请登录
PL08569-100mg 100mg 询价 询价
PL08569-200mg 200mg 询价 询价
PL08569-10mM*1mLinDMSO 10mM*1mLinDMSO ¥3873.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
UNC10217938A
英文名称
UNC10217938A
英文别名
UNC10217938A;Ethyl (8-((2-(dimethylamino)ethyl)amino)-2,3-diphenylpyrido[2,3-b]pyrazin-6-yl)carbamate;BDBM50359409;ethyl N-[8-(2-dimethylaminoethylamino)-2,3-diphenyl-pyrido[2,3-b]pyrazin-6-yl]carbamate;Ethyl N-[8-[2-(dimethylamino)ethylamino]-2,3-diphenylpyrido[2,3-b]pyrazin-6-yl]carbamate
Cas No.
1347749-97-6
分子式
C26H28N6O2
分子量
456.54
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
UNC10217938A 是一种具有强大的寡核苷酸 (oligonucleotides) 增强作用的 3-deazapteridine 类似物。UNC10217938A 通过调节寡核苷酸的细胞内运输和从内体释放来增强寡核苷酸的作用。UNC10217938A 还增强了反义和 siRNA 寡核苷酸的作用。
生物活性
UNC10217938A is a 3-deazapteridine analog with strong oligonucleotide enhancing effects. UNC10217938A enhances oligonucleotides effects by modulating their intracellular trafficking and release from endosomes. UNC10217938A also enhances the effects of antisense and siRNA oligonucleotides.
性状
Solid
体外研究(In Vitro)
UNC10217938A strongly enhances luciferase induction in HelaLuc705 cells when used in the 5-25 μM range and are substantially more effective and potent than Retro-1. As compared to splice switching oligonucleotide (SSO) alone, UNC10217938A provids a 60-fold enhancement at 10 μM and 220-fold at 20 μM, in contrast to a 11-fold enhancement for 100 μM Retro-1.
UNC10217938A can substantially enhance effects of receptor targeted oligonucleotide conjugates. UNC10217938A also can enhance effects of uncharged morpholino oligonucleotides as well as negatively charged oligonucleotides.
Exposure of cells to UNC10217938A leads to a major reduction in co-localization of the TAMRA-oliogonucleotide with the late endosome marker Rab7, but had little effect on co-localization with the lysosomal marker LAMP-1. UNC10217938A causes partial release of oligonucleotide from late endosomes to t
体内研究(In Vivo)
Systemic treatment with SSO623 followed by administration of UNC10217938A (7.5 mg/kg; intravenous injection) produces distinct increases in EGFP fluorescence in liver, kidney and heart in EGFP654 mice. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Yang B, et al. High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides. Nucleic Acids Res. 2015 Feb 27;43(4):1987-96.
溶解度数据
In Vitro: DMSO : 10 mg/mL (21.90 mM; ultrasonic and warming and heat to 80°C)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2